James Young

James F.
Young is currently a Director at CannaRoyalty Corp.
and President at MedImmune Oncology, Inc. Former roles include Chairman at Cloud3 Ventures, Inc., Chairman, Chief Executive & Financial Officer at Targeted Microwave Solutions, Inc. from 2017 to 2018, Chairman at Novavax, Inc. from 2011 to 2025, Director at Arriva Pharmaceuticals, Inc., Director at Xencor, Inc. from 2006 to 2008, Director at Valneva Usa, Inc. from 2002 to 2006, Independent Director at Sagimet Biosciences, Inc. from 2010 to 2023, Director-Molecular Genetics Department at Smith Kline & French Laboratories Ltd., President-Research & Development at MedImmune LLC from 2000 to 2008, Faculty Member-Microbiology Department at Icahn School of Medicine at Mount Sinai from 1978 to 1983, and Trustee at The Phillips Collection.
Education includes undergraduate studies at Villanova University and a doctorate from Baylor College of Medicine.